Evidence map›Paper›PMID 36471865›Full record

ArticleOxidative medicine and cellular longevity2022

Attenuation of the Severity of Acute Respiratory Distress Syndrome by Pomiferin through Blocking Inflammation and Oxidative Stress in an AKT/Foxo1 Pathway-Dependent Manner.

Zheng Tang, Zetian Yang, Hui Feng, Xuefeng Zhou, Ming Mao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zheng Tang *Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Zetian Yang *Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Hui Feng *Information Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Xuefeng ZhouDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.ORCID https://orcid.org/0000-0002-7424-7810
Ming MaoDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) gives rise to uncontrolled inflammatory response and oxidative stress, causing very high mortality globally. Pomiferin is a kind of prenylated isoflavonoid extracted from

Indexed as

BenzopyransIsoflavonesRespiratory Distress SyndromeAnimalsForkhead Box Protein O1InflammationLipopolysaccharidesMiceMice, Inbred C57BLOxidative StressProto-Oncogene Proteins c-aktBenzopyransForkhead Box Protein O1Foxo1 protein, mouseIsoflavonesLipopolysaccharidespomiferinProto-Oncogene Proteins c-akt

Identifiers

PMID36471865
PMCPMC9719418
OpenAlexW4309998752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.